Different profiles of isoelectric avian luteinizing hormone components in biological activity and immunoreactivity.
- 1 January 1983
- journal article
- research article
- Published by Japan Endocrine Society in Endocrinologia Japonica
- Vol. 30 (4) , 551-560
- https://doi.org/10.1507/endocrj1954.30.551
Abstract
Chicken LH [luteinizing hormone] components from the glycoprotein fraction of the anterior pituitary glands were separated to isoelectric homogeneity by means of isoelectric focusing, and investigated for their biological activities in vitro. The activities of these components were measured with LH receptor binding, cAMP accumulation and testosterone production in rat Leydig cells at equal doses expressed as immunoreactivity of IRC-2. All the components were active in the heterologous assay systems, although the relative potency expressed as the ratios of biological activity to immunoreactivity (B:I) differed significantly among the cmponents. Component I, the amount of which is the largest (40-50%), with the most alkaline isoelectric pint (pI), showed the highest B:I ratio, and the B:I ratio decreased with decreasing pI in the same way as in the rat LH components. Therfore, pituitary LH from photostimulated male quail, where the relative amount of component I was increased, was estimated to have higher B:I ratios than that from short-day (SD) treated male quail. Furthermore, the differences in activities among the components obtained by the 3 assays were in the following order: testosterone production > cAMP accumulation > receptor binding, suggesting that the hormonal actions of components with higher B:I ratios (I, II and III) are efficiently amplified in the biological response to the final step. In the incubation of pituitary glands with hypothalamic extracts, component I in the pituitary glands from the long-day (LD) treated group was mostly decreased after the incubation, while all the components were decreased in parallel in the SD-treated group. The LH component releasable to gonadoliberin changes in endocrine status through component I with the highest B:I ratio is relatively releasable in both SD- and LD-treated groups.This publication has 18 references indexed in Scilit:
- Isoelectric focusing and gel filtration studies on the heterogeneity of avian pituitary luteinizing hormoneGeneral and Comparative Endocrinology, 1979
- Purification and Subfractionation of Bovine Thyrotropin and Lutropin Using Radioimmunoassays for Evaluation of the Purification Processes1The Journal of Biochemistry, 1978
- Biological and immunological characterization of human luteinizing hormone: II. A comparison of the immunological and biological activities of pituitary extracts after electrofocusing using different standard preparationsMolecular and Cellular Endocrinology, 1977
- Biological and immunological characterization of human luteinizing hormone: I. Biological profile in pituitary and plasma samples after electrofocusingMolecular and Cellular Endocrinology, 1977
- Effects of chicken and ovine luteinizing hormone on androgen release and cyclic AMP production by isolated cells from the quail testisGeneral and Comparative Endocrinology, 1977
- Purification and Properties of Four Biologically Active Components of Whale Luteinizing HormoneThe Journal of Biochemistry, 1977
- Heterogeneity of rat luteinizing hormone revealed by radioimmunoassay and electrofocusing studies.Endocrinologia Japonica, 1977
- Effects of Luteinizing Hormone Releasing Hormone (LHRH) upon Bioactive and Immunoreactive Serum LH Levels in Normal SubjectsJournal of Clinical Endocrinology & Metabolism, 1976
- InVitroBioassay of LH in Human Serum: The Rat Interstitial Cell Testosterone (RICT) AssayJournal of Clinical Endocrinology & Metabolism, 1976
- Purification and properties of follicle-stimulating and luteinizing hormones from horse pituitary glandsArchives of Biochemistry and Biophysics, 1970